tradingkey.logo

BRIEF-Q32 Bio Inc To Discontinue Renal Basket Trial For Adx-097 To Conserve Resources

ReutersFeb 10, 2025 9:38 PM

Q32 Bio Inc QTTB.O:

  • Q32 BIO INC: TO DISCONTINUE RENAL BASKET TRIAL FOR ADX-097 TO CONSERVE RESOURCES

  • Q32 BIO INC: EVALUATE STRATEGIC OPTIONS FOR ITS TISSUE-TARGETED COMPLEMENT INHIBITOR PLATFORM

  • Q32 BIO INC: CASH RUNWAY EXPECTED TO EXTEND TO 2H'26

  • Q32 BIO INC: INITIATING OPEN-LABEL EXTENSION FROM SIGNAL-AA PART A IN 1H'25

  • Q32 BIO INC: SIGNAL-AA PART B REMAINS ON TRACK FOR INITIATION OF DOSING IN 1H'25, WITH TOPLINE DATA EXPECTED IN 1H'26

Source text: ID:nPn11yPfKa

Further company coverage: QTTB.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI